{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:00:03Z","timestamp":1789833603455,"version":"4.0.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T00:00:00Z","timestamp":1541721600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12969-018-0288-z","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T08:41:27Z","timestamp":1541752887000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Juvenile idiopathic arthritis managed in the new millennium: one year outcomes of an inception cohort of Australian children"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5834-8833","authenticated-orcid":false,"given":"Georgina","family":"Tiller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Buckle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Munro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gowdie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Akikusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,9]]},"reference":[{"issue":"9563","key":"288_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A. Juvenile idiopathic arthritis. Lancet (North American ed.). 2007;369(9563):767.","journal-title":"Lancet (North American ed.)"},{"key":"288_CR2","first-page":"205","volume":"3","author":"RE Petty","year":"1987","unstructured":"Petty RE. Epidemiology of juvenile rheumatoid arthritis World. Pediatr Child Care. 1987;3:205\u201310.","journal-title":"Pediatr Child Care"},{"issue":"4","key":"288_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/acr.20044","volume":"62","author":"K Oen","year":"2010","unstructured":"Oen K, et al. Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort. Arthritis care & research. 2010;62(4):527\u201336.","journal-title":"Arthritis care & research"},{"issue":"1","key":"288_CR4","doi-asserted-by":"publisher","first-page":"e000074","DOI":"10.1136\/rmdopen-2015-000074","volume":"1","author":"C Sengler","year":"2015","unstructured":"Sengler C, et al. The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohort. RMD Open. 2015;1(1):e000074.","journal-title":"RMD Open"},{"issue":"10","key":"288_CR5","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1136\/annrheumdis-2014-205372","volume":"74","author":"J Guzman","year":"2015","unstructured":"Guzman J, et al. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-out cohort. Ann Rheum Dis. 2015;74(10):1854\u201360.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"288_CR6","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1002\/art.30426","volume":"63","author":"E Nordal","year":"2011","unstructured":"Nordal E, et al. Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis & Rheumatism. 2011;63(9):2809\u201318.","journal-title":"Arthritis & Rheumatism"},{"issue":"3","key":"288_CR7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1136\/ard.2007.073445","volume":"67","author":"M Bartoli","year":"2008","unstructured":"Bartoli M, et al. The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis. Ann Rheum Dis. 2008;67(3):370\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"288_CR8","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1002\/art.34343","volume":"64","author":"CA Wallace","year":"2012","unstructured":"Wallace CA, et al. Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis & Rheumatism. 2012;64(6):2012\u201321.","journal-title":"Arthritis & Rheumatism"},{"key":"288_CR9","unstructured":"The Australian Institute of Health and Welfare. Juvenile arthritis in Australia. Arthritis series no. 7. Cat. no. PHE 101. 2008 [cited 2016 Aug 31]; Available from: \n                    http:\/\/www.aihw.gov.au\/publication-detail\/?id=6442468170\n                    \n                  ."},{"issue":"7","key":"288_CR10","first-page":"1520","volume":"29","author":"P Manners","year":"2002","unstructured":"Manners P, Bower C. Worldwide prevalence of juvenile arthritis\u2014why does it vary so much? J Rheumatol. 2002;29(7):1520\u201330.","journal-title":"J Rheumatol"},{"issue":"2","key":"288_CR11","first-page":"394","volume":"30","author":"SL Bowyer","year":"2003","unstructured":"Bowyer SL, et al. Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis. J Rheumatol. 2003;30(2):394\u2013400.","journal-title":"J Rheumatol"},{"issue":"2","key":"288_CR12","first-page":"343","volume":"35","author":"EM Behrens","year":"2008","unstructured":"Behrens EM, et al. Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania systemic onset juvenile arthritis registry (PASOJAR). J Rheumatol. 2008;35(2):343\u20138.","journal-title":"J Rheumatol"},{"key":"288_CR13","unstructured":"Ringold S K.Y, Schanberg LE, Natter MD, Xie F, Ilowite N, Jones J, Mieszkalski K, Beukelman T, Patterns of Medication Use in Children with Juvenile Idiopathic Arthritis: Results from the Childhood Arthritis & Rheumatology Research Alliance Registry [abstract]. 2016: Arthritis Rheumatol."},{"key":"288_CR14","unstructured":"DHHS A.G. Juvenile idiopathic arthritis: Initial PBS authority application. 2017 [cited 2017 13\/11\/12017]; Available from: \n                    https:\/\/www.humanservices.gov.au\/organisations\/health-professionals\/forms\/pb060\n                    \n                  ."},{"issue":"1","key":"288_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12969-017-0157-1","volume":"15","author":"Y Kimura","year":"2017","unstructured":"Kimura Y, et al. Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic juvenile idiopathic arthritis consensus treatment plans. Pediatr Rheumatol. 2017;15(1):23.","journal-title":"Pediatr Rheumatol"},{"issue":"2","key":"288_CR16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/art.30128","volume":"63","author":"PA Nigrovic","year":"2011","unstructured":"Nigrovic PA, et al. Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis & rheumatism. 2011;63(2):545\u201355.","journal-title":"Arthritis & rheumatism"},{"issue":"6","key":"288_CR17","first-page":"972","volume":"30","author":"J Anink","year":"2012","unstructured":"Anink J, et al. Two-year outcome of juvenile idiopathic arthritis in current daily practice: what can we tell our patients? Clinical & Experimental Rheumatology. 2012;30(6):972\u20138.","journal-title":"Clinical & Experimental Rheumatology"},{"issue":"9","key":"288_CR18","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1136\/ard.2010.143347","volume":"70","author":"P Tynjala","year":"2011","unstructured":"Tynjala P, et al. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial. Ann Rheum Dis. 2011;70(9):1605\u201312.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"288_CR19","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/art.11156","volume":"48","author":"M Boers","year":"2003","unstructured":"Boers M. Understanding the window of opportunity concept in early rheumatoid arthritis. Arthritis & Rheumatology. 2003;48(7):1771\u20134.","journal-title":"Arthritis & Rheumatology"},{"issue":"11","key":"288_CR20","first-page":"2290","volume":"31","author":"CA Wallace","year":"2004","unstructured":"Wallace CA, Ruperto N, Giannini E. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol. 2004;31(11):2290\u20134.","journal-title":"J Rheumatol"},{"issue":"4","key":"288_CR21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/acr.20667","volume":"64","author":"HA Van Mater","year":"2012","unstructured":"Van Mater HA, et al. Psychometric characteristics of outcome measures in juvenile idiopathic arthritis: a systematic review. Arthritis care & research. 2012;64(4):554\u201362.","journal-title":"Arthritis care & research"},{"issue":"5","key":"288_CR22","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/art.24516","volume":"61","author":"A Consolaro","year":"2009","unstructured":"Consolaro A, et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis & Rheumatism. 2009;61(5):658\u201366.","journal-title":"Arthritis & Rheumatism"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-018-0288-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12969-018-0288-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-018-0288-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T19:11:57Z","timestamp":1573240317000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-018-0288-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,9]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["288"],"URL":"https:\/\/doi.org\/10.1186\/s12969-018-0288-z","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,9]]},"assertion":[{"value":"12 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Royal Children\u2019s Hospital (RCH) Human Research Ethics Committee approved the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have consented to publication of the manuscript. Individual person\u2019s data: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"69"}}